SGS receives regulatory approval to restart human ¹⁴C ADME trials
Antwerp, Belgium (February 16, 2026) – SGS today announced it has received formal approval from the Belgian Federal Agency for Nuclear Control (FANC) to resume human ADME (Adsorption, Distribution, Metabolism and Excretion) studies using ¹⁴C-radiolabeled investigational products. The approval enables SGS to reintroduce ¹⁴C human ADME studies at its clinical pharmacology unit in Antwerp, reinstating
SGS receives regulatory approval to restart human ¹⁴C ADME trials Read More »










